Stock Price
21.49
Daily Change
-4.32%
Yearly
-6.52%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Acadia Pharmaceuticals 18.79 -0.99 -5.01% -66.45%
Aurora Cannabis Inc 8.45 -0.11 -1.29% -38.50%
ANI Pharmaceuticals 40.77 -1.26 -3.00% 38.30%
Aphria Inc 16.55 -0.98 -5.59% 225.79%
Ardelyx 0.89 -0.03 -3.47% -85.86%
BioDelivery Sciences International 2.91 -0.10 -3.32% -23.82%
BioMarin Pharmaceutical 87.58 -1.99 -2.22% 8.93%
Bristol-Myers Squibb 56.53 -0.28 -0.49% -10.34%
Corcept Therapeutics 21.49 -0.97 -4.32% -6.52%
Depomed 1.54 0.13 8.83% 271.98%
Eleven Biotherapeutics 1.08 -0.01 -0.92% -10.74%
Esperion Therapeutics 7.78 0.09 1.17% -71.21%
Knight Therapeutics Inc 5.30 -0.06 -1.12% -3.99%
GW Pharmaceuticals 218.96 0 0% 108.53%
Johnson & Johnson 159.20 -1.04 -0.65% 10.56%
Lannett 1.72 0.03 1.78% -73.08%
Eli Lilly 260.37 -1.63 -0.62% 76.59%
Lexicon Pharmaceuticals 4.74 -0.40 -7.78% 192.59%
Merck & Co 79.16 -3.12 -3.79% -0.88%
Nektar Therapeutics 11.21 -0.41 -3.53% -33.23%
Novartis 74.72 -1.85 -2.42% -7.82%
Novartis 80.70 -1.21 -1.48% -10.09%
Omeros 7.43 -0.37 -4.74% -36.71%
Pacira 51.63 -2.62 -4.83% -19.08%
Pfizer 54.00 3.11 6.11% 45.04%
Supernus Pharmaceuticals 30.61 -1.33 -4.16% 39.96%
TG Therapeutics 23.98 -1.43 -5.63% -20.83%
Canopy Growth Corp 14.81 -0.36 -2.37% -60.51%
Ziopharm Oncology 1.35 -0.07 -4.93% -53.61%

Indexes Price Day Year
US2000 2246 -85.52 -3.67% 21.06%
NASDAQ 15492 -353.57 -2.23% 26.92%

Corcept Therapeutics
Corcept Therapeutics Incorporated is a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the steroid hormone cortisol. The Company has marketed the cortisol modulator Korlym in the United States for the treatment of patients with a form of hypercortisolism known as endogenous Cushing’s syndrome. Cortisol activity can be modulated effectively by a drug that competes with cortisol as it attempts to bind to the glucocorticoid receptor (GR). The Company’s active ingredient, mifepristone, reduces the binding of excess cortisol to GR. Its portfolio of selective cortisol modulators consists of four structurally distinct series, including relacorilant, exicorilant and miricorilant. These compounds bind to GR but not the progesterone, estrogen or androgen receptors.